Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow-to-Debt Ratio
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥69.15 Million could theoretically repay 0% of its total liabilities (CN¥2.84 Billion) in one year. Explore 000153 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Anhui Fengyuan Pharmaceutical Co Ltd across 27 annual periods. Also explore 000153 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year debt coverage analysis for Anhui Fengyuan Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market cap of Anhui Fengyuan Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥119.30 Million | CN¥2.93 Billion | ▼ -14.5% |
| 2024 | 0.05x | CN¥126.24 Million | CN¥2.65 Billion | ▼ -53.8% |
| 2023 | 0.10x | CN¥254.75 Million | CN¥2.47 Billion | ▼ -36.4% |
| 2022 | 0.16x | CN¥439.99 Million | CN¥2.71 Billion | ▲ +53.9% |
| 2021 | 0.11x | CN¥237.88 Million | CN¥2.26 Billion | ▼ -21.3% |
| 2020 | 0.13x | CN¥292.75 Million | CN¥2.19 Billion | ▲ +351.1% |
| 2019 | 0.03x | CN¥66.21 Million | CN¥2.23 Billion | ▼ -78.2% |
| 2018 | 0.14x | CN¥233.59 Million | CN¥1.72 Billion | ▲ +301.9% |
| 2017 | 0.03x | CN¥52.40 Million | CN¥1.55 Billion | ▼ -42.1% |
| 2016 | 0.06x | CN¥78.21 Million | CN¥1.34 Billion | ▲ +44.1% |
| 2015 | 0.04x | CN¥45.50 Million | CN¥1.12 Billion | ▲ +321.1% |
| 2014 | 0.01x | CN¥10.51 Million | CN¥1.09 Billion | ▲ +112.7% |
| 2013 | -0.08x | CN¥-70.31 Million | CN¥926.72 Million | ▼ -212.3% |
| 2012 | 0.07x | CN¥45.65 Million | CN¥675.47 Million | ▼ -32.1% |
| 2011 | 0.10x | CN¥55.06 Million | CN¥552.99 Million | ▼ -5.6% |
| 2010 | 0.11x | CN¥55.04 Million | CN¥522.02 Million | ▲ +71.4% |
| 2009 | 0.06x | CN¥32.41 Million | CN¥526.78 Million | ▼ -36.8% |
| 2008 | 0.10x | CN¥49.82 Million | CN¥511.47 Million | ▼ -20.7% |
| 2007 | 0.12x | CN¥55.26 Million | CN¥449.73 Million | ▲ +50.8% |
| 2006 | 0.08x | CN¥36.27 Million | CN¥445.10 Million | ▲ +15.2% |
| 2005 | 0.07x | CN¥34.88 Million | CN¥493.08 Million | ▲ +284.0% |
| 2004 | -0.04x | CN¥-11.72 Million | CN¥304.86 Million | ▲ +46.0% |
| 2003 | -0.07x | CN¥-11.46 Million | CN¥160.93 Million | ▼ -184.0% |
| 2002 | 0.08x | CN¥10.48 Million | CN¥123.55 Million | ▼ -37.6% |
| 2001 | 0.14x | CN¥23.57 Million | CN¥173.33 Million | ▼ -46.3% |
| 2000 | 0.25x | CN¥25.88 Million | CN¥102.28 Million | ▲ +1939.0% |
| 1999 | 0.01x | CN¥1.01 Million | CN¥81.65 Million | — |